期刊文献+

Fibulin-1在2型糖尿病微血管病变患者血清中的表达 被引量:2

下载PDF
导出
摘要 目的:探究2 型糖尿病微血管病变患者血清中腓骨蛋白-1(Fibulin-1)的表达,初步分析Fibulin-1 与糖尿病微血管病变的相关性。方法:选取糖尿病合并微血管病变患者62 例、单纯糖尿病患者18 例及健康体检者20 例,采用酶联免疫吸附法检测患者血清中Fibulin-1 的含量,并应用SPSS 软件分析Fibulin-1 与糖尿病微血管病变的相关性。结果:糖尿病患者血清Fibulin-1 含量显著高于健康人群(P<0.05);合并微血管病变的糖尿病患者血清Fibulin-1 含量显著高于单纯糖尿病患者(P<0.05),血清中Fibulin-1 浓度与空腹血糖值呈正相关。同时,合并糖尿病视网膜病变和糖尿病肾病患者血清中Fibulin-1 表达显著高于仅合并一种微血管病变者(P<0.05)。结论:Fibulin-1 在糖尿病微血管病变发生、发展过程中发挥重要作用。
出处 《南通大学学报(医学版)》 2019年第2期151-153,共3页 Journal of Nantong University(Medical sciences)
  • 相关文献

参考文献5

二级参考文献50

  • 1Ejaz S,Chekarova I,Ejaz A,et al.Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.Diabetes Obes Metab,2008,10(1):53-63.
  • 2Wolf G,Chen S,Ziyadeh FN.From the periphery of the glomerular capillary wall toward the center of disease:podocyte injury comes of age in diabetic nephropathy.Diabetes,2005,54(6):1626-1634.
  • 3Yan SF,Ramasamy R,Schmidt AM.Mechanisms of disease:advanced glycation end-products and their receptor in inflammation and diabetes complications.Nat Clin Pract Endocrinol Metab,2008,4(5):285-293.
  • 4Yamamoto Y,Kato I,Doi T,et al.Development and prevention of advanced diabetic nephropathy in RAGE overexpressing mice.J Clin Invest,2001,108(2):261-268.
  • 5Thallas-Bonke V,Thorpe SR,Coughlan MT,et al.Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.Diabetes,2008,57(2):460-469.
  • 6Tuttle KR,Anderberg RJ,Cooney SK,et al.Oxidative Stress Mediates Protein Kinase C Activation and Advanced Glycation End Product Formation in a Mesangial Cell Model of Diabetes and High Protein Diet.Am J Nephrol,2008,29(3):171-180.
  • 7Yokota T,Ma RC,Park JY,et al.Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes.Diabetes,2003,52(3):829-837.
  • 8Idris I,Gray S,Donnelly R.Protein Kinase C activation:isozyme-specific effects on metabolism and cardiovascular complications in diabetes.Diabetologia,2001,44(6):659-673.
  • 9Tuttle KR,Bakris GL,Toto RD,et al.The effect of ruboxistaurin on nephropathy in type 2 diabetes.Diabetes Care,2005,28(11):2686-2690.
  • 10Shah DI,Singh M.Activation of protein kinase A improves vascular endothelial dysfunction.Endothelium,2006,13(4):267-277.

共引文献6762

同被引文献27

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部